期刊文献+

原发性胆汁性胆管炎患者中人工肝支持系统的应用 被引量:4

Application of artificial liver support system in patients with primary biliary cholangitis
下载PDF
导出
摘要 原发性胆汁性胆管炎(primary biliary cholangitis,PBC)是一种病因不明的自身免疫性胆汁淤积性肝病,部分患者常出现顽固性瘙痒及严重的高胆红素血症,目前临床上药物治疗有限,晚期并发症多,预后差,严重影响患者生存质量。当前,可暂时替代肝脏部分功能的非生物型人工肝治疗模式在临床上广泛应用,但应用非生物性人工肝治疗PBC患者的研究甚少,现将国内外相关研究进展综述如下。 Primary Biliary Cholangitis(PBC)is autoimmune cholestatic liver disease of unknown etiology,refractory pruritus and severe hyperbilirubinemia often occur in some patients,currently,drug therapy is limited,late complications and poor prognosis,seriously affect the quality of life of patients.Non⁃bioartificial liver treatment model,which can temporarily replace part of liver function,are widely used in clinical practice.However,there are few studies on the application of non⁃biological artificial liver in the treatment of PBC patients.The research progress in recent years are summarized as follows.
作者 党富涛 唐映梅 谭绪 徐加敏 杨秋瑾 DANG Futao;TANG Yingmei;TAN Xu;XU Jiamin;YANG Qiujin(Department of Gastroenterology,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,China)
出处 《实用医学杂志》 CAS 北大核心 2020年第22期3153-3156,共4页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:81660102,81360072)。
关键词 人工肝 胆管炎 肝衰竭 瘙痒 artificial liver sclerosing cholangitis liver failure pruritus
  • 相关文献

参考文献5

二级参考文献36

  • 1Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis EJ]. Korean J Hepatol, 2011, 17(3).-173-179.
  • 2Nguyen DL1, Juran BD,Lazaridis KN,et al. Primary biliary cirrhosis E J-I- Best Pract Res Clin Gastroen- terol. 2010,24(5) :647-654.
  • 3Lan RY, Salunga TL, Tsuneyama K, et al. Hepatic IL- 17 responses in human and murine primary biliary cir- rhosisEJ]. J Autoimmun. 2009,32(1):43-51.
  • 4Afzali B,Lombardi G,Lechler RI,et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in hu- man organ transplantation and autoimmune disease [J]. Clin Exp Immunol. 2007,148(1) :32-46.
  • 5Lampropoulou V, Hoehlig K, Roch T, et al. TLR-acti- rated B cells suppress T cell-mediated autoimmunity EJ]. J Immunol. 2008,180(7) :4763-4773.
  • 6Corpechot C, Poujol-Robert A, Wendum D, et al. Bio- chemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with pri- mary biliary cirrhosis EJ]. Liver Int. 2004,24 (3) : 187- 193.
  • 7Kuiper EM, Hansen BE,de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acidEJ]. Gastroenterology. 2009,136(4) : 1281~1287.
  • 8Par6s A, Caballeria L, Rod6s J,et al. Excellent long- term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic AcidEJ]. Gastroenterology. 2006,130 ( 3 ) : 715- 720.
  • 9董庆华,郭利民,王宇,熊号峰,张红宇,刘小冬.CAPS人工肝治疗肝衰竭的临床研究[J].实用肝脏病杂志,2009,12(5):352-354. 被引量:9
  • 10高远征,贾素华,刘玉英,张守民,王研,赵连峰,魏兴辉.异基因脐血干细胞移植治疗失代偿期肝硬化的疗效观察[J].临床肝胆病杂志,2010,26(6):613-614. 被引量:14

共引文献576

同被引文献15

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部